MedTrace Logo

MIND Diet Intervention and Cognitive Decline

NCT02817074 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 604

Last updated 2022-03-23

No results posted yet for this study

Summary

Phase III randomized controlled trial designed to test the effects of a 3-year intervention of the MIND diet (Mediterranean-DASH Intervention for Neurodegenerative Delay) on cognitive decline and brain neurodegeneration among 600 individuals 65+ years without cognitive impairment who are overweight and have suboptimal diets.

Conditions

Interventions

BEHAVIORAL

MIND Diet

3-year dietary counseling to adhere to the MIND diet and for mild weight loss

BEHAVIORAL

Mild Weight Loss

3-year dietary counseling to reduce calorie intake by 250 kcal/day for mild weight loss

Sponsors & Collaborators

  • Harvard School of Public Health (HSPH)

    collaborator OTHER

  • Brigham and Women's Hospital

    collaborator OTHER

  • National Institute on Aging (NIA)

    collaborator NIH

  • Rush University Medical Center

    lead OTHER

Principal Investigators

  • Lisa L Barnes, Ph.D. · Rush University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
84 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02817074 on ClinicalTrials.gov